The cost of validation is planned and controllable. The cost of inadequate validation is often unexpected, disruptive, and substantially higher."
Cost of delay
ISOCHECKS investment
↓
Faster, controlled implementation
↓
Earlier clinical service delivery
↓
Earlier return on laboratory investment

Failure to validate a diagnostic service properly can expose laboratories to significant financial, operational, regulatory, and clinical risks.
A robust validation programme typically costs a fraction of the expenses associated with remediation, regulatory findings, or delayed implementation.
Typical Cost: £2,000 to £10,000
Typical Cost: £10,000 to £50,000+
Typical Cost: £25,000 to £100,000+
Typical Cost: £50,000 to £500,000+
Typical Cost : £100,000 to £1M+
This matrix can be used to help laboratories quantify the business risk associated with inadequate or delayed validation activities.
Medium Risk: Non-conformity requiring corrective action (£5k-15k).
Severe Risk: Loss of accreditation or suspended service (£50k+).
Medium Risk: Repeat validation studies (£5k-20k)
Severe Risk: Dedicated recovery project (£50k+)
Medium Risk: 1-3 months (£10k-30k)
Severe Risk: Project failure or cancellation (£100k+)
Medium Risk: Loss of referrals (£25k-100k)
Severe Risk: Contract loss or service decommissioning (£100k+)
Medium Risk: delay in diagnosis
Severe Risk: Potential diagnostic error. Significant incident requiring investigation.
If external specialist support gets your service live weeks earlier, the investment in validation can be small compared with the cost of delay.